Transatlantic Australasian Retroperitoneal Sarcoma Working Group

A collaborative group for Surgical Oncologists and Sarcoma Professionals

RESAR Study

REtroperitoneal SArcoma Registry (RESAR): prospective collection of primary retroperitoneal sarcoma patient’s data, radiological and pathological material for the TransAtlantic Retroperitoneal Sarcoma Working Group.

Documents for activation of RESAR at new centers are available here.

Activation track of the study (updated December 20th 2020)

City Institution State Activation Status
1 Amsterdam Netherlands Cancer Institute The Netherlands Recruiting
2 Atlanta Winship Cancer Institute, Emory University Georgia, USA Recruiting
3 Barcelona Hospital Sant Pau Spain Recruiting
4 Baton Rouge Mary Bird Perkins Cancer Center Louisiana, USA Recruiting
5 Beijing Peking University International Hospital China Recruiting
6 Birmingham Queen Elizabeth Hospital Birmingham UK Recruiting
7 Bordeaux Institut Bergonié France Recruiting
8 Boston Brigham and Women’s Hospital/Dana-Farber Cancer Institute Massachusetts, USA Recruiting
9 Brisbane Princess Alexandra Hospital Australia Recruiting
10 Buffalo Roswell Park Comprehensive Cancer Center New York, USA Recruiting
11 Candiolo Candiolo Cancer Institute Italy Recruiting
12 Columbus The Ohio State University Ohio, USA Recruiting
13 Jacksonville Mayo Clinic Florida, USA Recruiting
14 Leiden Leiden University Medical Center The Netherlands Recruiting
15 Ljubljana Institute of Oncology Ljubljana Slovenia Recruiting
16 London Royal Marsden Hospital UK Recruiting
17 Los Angeles University of Southern California (USC) California, USA Recruiting
18 Melbourne Peter MacCallum Cancer Center Victoria, Australia Recruiting
19 Milano Fondazione IRCCS Istituto Nazionale dei Tumori Italy Recruiting
20 Milano European Institute of Oncology Italy Recruiting
21 Montreal Maisonneuve-Rosemont Hospital / University of Montreal Quebec, Canada Recruiting
22 Munich Ludwig Maximilian University Germany Recruiting
23 Murcia Hospital Clinico Universitario “Virgen de la Arrixaca” Spain Recruiting
24 Ottawa The Ottawa Hospital Ontario, Canada Recruiting
25 Padova Veneto Institute of Oncology Italy Recruiting
26 Paris Institut Curie France Recruiting
27 Roma Campus Biomedico Italy Recruiting
28 Rozzano Humanitas Cancer Center Italy Recruiting
29 San Diego UC San Diego USA Recruiting
30 Seattle University of Washington Washington, USA Recruiting
31 Seoul Samsung Medical Center South Corea Recruiting
32 Tampa Moffitt Cancer Center Florida, USA Recruiting
33 Tel-Aviv Tel-Aviv Sourasky Medical Center Israel Recruiting
34 Tokyo National Cancer Center Hospital Japan Recruiting
35 Toronto Mount Sinai / Princess Margaret Canada Recruiting
36 Verona Ospedale Borgo Roma Italy Recruiting
37 Warsaw  Maria Sklodowska-Curie Memorial Cancer Center and Institute ofOncology, Warsaw, Poland Recruiting
1 Dublin Tallaght Univesity Hospital Ireland Approved, ready to recruit
2 Miami Sylvester Comprehensive Cancer Center Florida, USA Approved, ready to recruit
3 Porto Portuguese Institute for Oncology Porto IPO Portugal Approved, ready to recruit
4 Saitama Saitama Medical Center, Jichi Medical University Japan Approved, ready to recruit
5 Sydney Royal Prince Alfred Hospital Australia Approved, ready to recruit
6 Vellore Christian Medical College India Approved, ready to recruit
1 Durham Duke University North Carolina, USA Submitted to IRB, pending for decision
2 Karachi Patel Hospital Pakistan Submitted to IRB, pending for decision
3 Montreal McGill University Canada Submitted to IRB, pending for decision
4 Turin Città della Salute e della Scienza Italy Submitted to IRB, pending for decision
1 Ann Arbor University of Michigan Michigan, USA Planning to submit to IRB
2 Athens University of Athens Greece Planning to submit to IRB
3 Baltimore Johns Hopkins University Maryland, USA Planning to submit to IRB
4 Boston Massachusetts General Hospital Massachusetts, USA Planning to submit to IRB
5 Catania Ospedale Garibaldi Italy Planning to submit to IRB
6 Gent Ghent University Hospital Belgium Planning to submit to IRB
7 Hong Kong The Chinese University of Hong Kong / Prince of Wales Hospital Hong Kong Planning to submit to IRB
8 Leuven UZ Leuven The Netherlands Planning to submit to IRB
9 Madrid Hospital Gregorio Maranon Spain Planning to submit to IRB
10 Mexico City Instituto National de Cancerologia Mexico Planning to submit to IRB
11 Milwaukee Aurora St. Luke’s Medical Center Wisconsin, USA Planning to submit to IRB
12 Moskow N.N. Blokhin Medical Research Center of Oncology Russia Planning to submit to IRB
13 Mumbai Tata Memorial Hospital India Planning to submit to IRB
14 New Delhi All India Institute of Medical Science AIIMS India Planning to submit to IRB
15 New Haven Yale New Haven Hospital Connecticut, USA Planning to submit to IRB
16 Philadelphia Fox Chase Cancer Center Pennsylvania, USA Planning to submit to IRB
17 Sacramento UC Davis California, USA Planning to submit to IRB
<span>%d</span> bloggers like this: